Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | -95,247 | N/A | -54,588 |
| Depreciation Amortization | N/A | 416 | N/A | 156 |
| Accounts payable and accrued liabilities | N/A | 577 | N/A | 543 |
| Other Working Capital | N/A | 12,921 | N/A | 11,194 |
| Other Operating Activity | 0 | 9,673 | 0 | 2,703 |
| Operating Cash Flow | $N/A | $-71,660 | $N/A | $-39,992 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | N/A | 66,095 | N/A | -148,453 |
| PPE Investments | N/A | -533 | N/A | -39 |
| Other Investing Activity | 0 | 0 | 0 | 2,406 |
| Investing Cash Flow | $N/A | $65,562 | $N/A | $-146,086 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 0 | 383,988 | 0 | 206,238 |
| Financing Cash Flow | $N/A | $383,988 | $N/A | $206,238 |
| Beginning Cash Position | N/A | 30,983 | N/A | 250 |
| End Cash Position | N/A | 408,873 | N/A | 20,410 |
| Net Cash Flow | $N/A | $377,890 | $N/A | $20,160 |
| Free Cash Flow | ||||
| Operating Cash Flow | N/A | -71,660 | N/A | -39,992 |
| Capital Expenditure | N/A | -533 | N/A | -39 |
| Free Cash Flow | 0 | -72,193 | 0 | -40,031 |